Approximately 55,100 new cases of prostate cancer are diagnosed every year in the UK More: MHRA approves prostate cancer imaging agent trofolastat Source: News
read moreAs the countdown to the launch of its first therapeutic continues, Rocket Pharmaceuticals is fueling up its commercial team. More: Rocket boosts preparations for gene therapy launch with new commercial chief from J&J, AstraZeneca Source: fierce
read moreAlthough President Trump’s “Liberation Day” tariffs have spared pharmaceuticals, potential drug-specific import levies remain a sword of Damocles creating anxiety among biopharma companies. Some industry leaders now fear that more than $100 billion in investments could leave the European Union.
read moreThe HHS secretary called out the measles vaccines as “the most effective way” to prevent the spread as an outbreak in Texas claims a second life. More: RFK Jr. promotes measles vaccine as Texas outbreak continues Source: fierce
read moreLooking to grow production in Latin America’s biggest country, Novo Nordisk is charting a $1.09 billion expansion at its manufacturing plant in Brazil. The investment will “significantly” bolster the facility’s capacity to crank out a variety of injectables, including GLP-1
read moreLess than a year after purchasing private cell therapy company ImmPact Bio to help refresh its ailing CAR-T pipeline, manufacturing considerations have prompted Lyell Immunopharma to cut staff at its new subsidiary and mothball a California facility picked up in
read more© 1994 - 2026 B.M. Pharmaceuticals